Hyperbaric Oxygen therapy’s role in Stem Cell transplantation for type 1 Diabetes
December 27, 2013
Human Embryonic stem cells have gained wide acceptance for the potential benefit of many conditions. Type 1 Diabetes is one of these conditions where this procedure is being tested. However, these stem cells have consistently failed to generate meaningful numbers of mature, functional β cells. Since oxygen is a strong driver of differentiation, researchers of this animal study looked at applying hyperbaric oxygen therapy to a group of rats following transplanted cells and observed an increase in the maturation of these cells, leading to increased insulin production. The future of embryonic stem cells may be to drive the differentiation and maturation of these cell by following the procedure with a course of hyperbaric oxygenation therapy.